Direxion Daily Semiconductor Bull 3X Shares vs 10X Genomics Inc — how do they compare? Direxion Daily Semiconductor Bull 3X Shares trades at $139.44 (market cap $24.42B), while 10X Genomics Inc trades at $82.5 (market cap $10.07B). The key difference: Direxion Daily Semiconductor Bull 3X Shares is far larger — about 2.4× 10X Genomics Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, Direxion Daily Semiconductor Bull 3X Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Direxion Daily Semiconductor Bull 3X Shares for 15 Days and 10X Genomics Inc for 91 Days on average.
| SOXL | TXG | |
|---|---|---|
Market Cap | $24.42B | $10.07B |
Volume | 100,232,380 | 5,657,286 |
Sector | Leveraged / Inverse | Health |
52-Week High | $300.77 | $97.74 |
52-Week Low | $30.81 | $11.48 |
Typical Hold Time | 15 Days | 91 Days |
Enterprise Value | — | $9.59B |
Signals from Pluang's Aura AI — not financial advice
SOXL, the Direxion Daily Semiconductor Bull 3X ETF, trades at $141.3, down 11.08% with a bearish technical signal despite bullish moving averages. The semiconductor sector shows volatility with mixed news flow, ranging from strong AI demand to regulatory and tariff concerns. Recent price action reflects the leveraged ETF's sensitivity to chip stock movements, with support at $134 and resistance at $145.
Outlook remains cautious due to high leverage amplifying sector swings. Opportunities exist if semiconductor fundamentals strengthen, but risks include overcrowded trades and macroeconomic headwinds. Investors should weigh the ETF's structure against direct semiconductor exposure for risk management.
10x Genomics (TXG) trades at $82.37, up 8.24% over 24 hours, with a bearish technical signal and mixed analyst sentiment. The company reported a net loss of $43.54M in 2025, but revenue grew to $642.82M, and it has beaten EPS estimates for three consecutive quarters. Recent news highlights strong demand for its Atera platform and a patent victory, though profitability remains a challenge.
The outlook is cautiously optimistic, with growth potential from new product launches and spatial biology demand, but risks include persistent losses, high valuation multiples, and competitive pressures. The consensus price target is $74.30, below the current price, suggesting limited near-term upside.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
SOXL is a leveraged ETF that seeks daily investment results corresponding to 300% of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bullish (long) position on the semiconductor sector. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXL →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →